RECALMIN II. Eight years of hospitalisation in Internal Medicine Units (2007-2014). What has changed?
Related Experiment Video
Updated: Feb 23, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A Zapatero-Gaviria1, R Barba-Martín2, J Canora Lebrato1
1Servicio de Medicina Interna, Hospital Universitario de Fuenlabrada, Madrid, España.
Objectives:
To analyse the evolution of care provided by the internal medicine units (IMU) of the Spanish National Health System from 2007 to 2014.
Material And Methods:
We analysed all discharges from the IMU of the Spanish National Health System in 2007 and 2014, using the Minimum Basic Data Set. We compared the risk factors by episode, mortality and readmissions between the two periods. We prepared specific fits for the risk for mortality and readmissions in heart failure, pneumonia and chronic obstructive pulmonary disease, as well as the Charlson index for all activity.
Results:
Discharges from the IMU between the two periods increased 14%. The average patient age increased by 2.8 years (71.2±17.1 vs. 74±16.2; p<.001), with a marked increase in comorbidity (Charlson index, 4±3.7 vs. 4.7±3.9; p<.001; 24% increase in risk factors per episode). The adjusted mortality rates decreased slight but significantly, with a slight increase in readmissions.
Conclusions:
During the analysed period, there was an increase of almost 3 years in the mean age of patients treated in the IMU of the Spanish National Health System, with a marked increase in comorbidity. These results should lead to a more appropriate assignment of nurse workloads and an increased implementation of good practices in clinical management.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Hospitals-II
Nurses that work in...
Rheumatic Heart Disease IV: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

